U.S. Markets open in 9 hrs 1 min

Questcor reports September Acthar paid prescriptions

Questcor reported Acthar paid prescriptions for September of 105-110 in Nephrotic Syndrome and 400-410 in Multiple Sclerosis. This compares to 119 and 508, respectively, in August. Questcor said patients with "serious, difficult-to-treat medical conditions continue to have access to Acthar, through commercial insurance, Medicare, Medicaid and other government programs as well as through our free drug program."